Autologous Human Schwann Cell Therapy(United States Department Of Defense)

N/A

Report date: 2022/12/27 09:23:01

Base Information

Drug NameAutologous Human Schwann Cell Therapy(United States Department Of Defense)
Drug Alias NameAutologous Human Schwann Cell (ahSC, United States Department Of Defense)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsPeripheral Nerve Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUnited States Department Of Defense
China Registration ClassN/A

Develop Information

Active CompaniesUnited States Department Of Defense
Inactive CompaniesN/A
Active IndicationsPeripheral Nerve Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A